GUAIFENESIN 200MG- guaifenesin tablet 
Health Pharma USA LLC

----------

Guaifenesin 200 mg

Active ingredient (in each tablet)

Guaifenesin 200 mg

Purpose

Expectorant

Uses

Warnings

ask a doctor before use if you have

When using this product

  • do not exceed recommended dosage
  • do not use for more than 7 days

Stop use and ask a doctor if

  • cough lasts for more than 7 days, recurs, or is accompanied by fever, rash, or persistent headache.

These could be signs of a serious condition.

If pregnant or breast- feeding,

ask a health professional before use.

Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

Other Information

Inactive ingredients

maltodextrin, povidone, microcrystalline cellulose, croscarmellose sodium, magnesium stearate, silicon dioxide, stearic acid

Questions or comments?

Call 1-844-832-1138

Monday - Friday 9AM – 5PM

PRINCIPAL DISPLAY PANEL

Guaifenesin 200 mg

Expectorant

label

GUAIFENESIN 200MG 
guaifenesin tablet
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:71679-148
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
GUAIFENESIN (UNII: 495W7451VQ) (GUAIFENESIN - UNII:495W7451VQ) GUAIFENESIN200 mg
Inactive Ingredients
Ingredient NameStrength
MALTODEXTRIN (UNII: 7CVR7L4A2D)  
POVIDONE (UNII: FZ989GH94E)  
MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  
MAGNESIUM STEARATE (UNII: 70097M6I30)  
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
STEARIC ACID (UNII: 4ELV7Z65AP)  
Product Characteristics
ColorwhiteScoreno score
ShapeROUNDSize8mm
FlavorImprint Code G2
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:71679-148-3030 in 1 BOTTLE; Type 0: Not a Combination Product03/26/2019
2NDC:71679-148-02200 in 1 BOTTLE; Type 0: Not a Combination Product03/26/2019
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM01203/26/2019
Labeler - Health Pharma USA LLC (080804485)
Establishment
NameAddressID/FEIBusiness Operations
Health Pharma USA LLC080804485manufacture(71679-148)

Revised: 10/2023
Document Id: 08da11ea-210b-8df3-e063-6294a90a7e8f
Set id: d68222f7-b796-7b27-e053-2995a90a2efe
Version: 4
Effective Time: 20231020
 
Health Pharma USA LLC